
Presented at #LIVES2023: In a randomized trial involving critically ill patients who had undergone mechanical ventilation for 3 days, a 3-day course of inhaled amikacin reduced the burden of ventilator-associated pneumonia. Full AMIKINHAL trial results: nej.md/472lySJ











